151 related articles for article (PubMed ID: 35512072)
21. Ex vivo retrieval and cryopreservation of oocytes from oophorectomized specimens for fertility preservation in a BRCA1 mutation carrier with ovarian cancer.
Pereira N; Hubschmann AG; Lekovich JP; Schattman GL; Rosenwaks Z
Fertil Steril; 2017 Aug; 108(2):357-360. PubMed ID: 28629583
[TBL] [Abstract][Full Text] [Related]
22. Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation.
Schon SB; Shapiro M; Gracia C; Senapati S
J Assist Reprod Genet; 2017 Sep; 34(9):1207-1215. PubMed ID: 28656539
[TBL] [Abstract][Full Text] [Related]
23. Oocyte cryopreservation for fertility preservation in women with cancer.
Domingo J; Garcia-Velasco JA
Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):465-469. PubMed ID: 27685935
[TBL] [Abstract][Full Text] [Related]
24. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
[TBL] [Abstract][Full Text] [Related]
25. Fertility Preservation Through Oocyte Cryopreservation in a Patient with Ovarian Dysgerminocarcinoma: A Case Report.
Brezina PR; Ding J; Ke RW; Klosky JL; Tillmanns TD
J Reprod Med; 2015; 60(9-10):441-4. PubMed ID: 26592073
[TBL] [Abstract][Full Text] [Related]
26. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons.
Cobo A; García-Velasco JA; Remohí J; Pellicer A
Fertil Steril; 2021 May; 115(5):1091-1101. PubMed ID: 33933172
[TBL] [Abstract][Full Text] [Related]
27. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
28. Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?
Lee JA; Barritt J; Moschini RM; Slifkin RE; Copperman AB
Fertil Steril; 2013 Apr; 99(5):1356-62. PubMed ID: 23266213
[TBL] [Abstract][Full Text] [Related]
29. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
30. Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue.
Yin H; Jiang H; Kristensen SG; Andersen CY
J Assist Reprod Genet; 2016 Jun; 33(6):741-6. PubMed ID: 26984232
[TBL] [Abstract][Full Text] [Related]
31. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
32. Fertility preservation in women with cervical cancer.
Somigliana E; Mangili G; Martinelli F; Noli S; Filippi F; Bergamini A; Bocciolone L; Buonomo B; Peccatori F
Crit Rev Oncol Hematol; 2020 Oct; 154():103092. PubMed ID: 32896752
[TBL] [Abstract][Full Text] [Related]
33. Fertility preservation in childhood and adolescent female tumor survivors.
Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
[TBL] [Abstract][Full Text] [Related]
34. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
35. Fertility preservation in ovarian cancer patients.
Santos ML; Pais AS; Almeida Santos T
Gynecol Endocrinol; 2021 Jun; 37(6):483-489. PubMed ID: 33501866
[TBL] [Abstract][Full Text] [Related]
36. Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women.
Kim SY; Kim SK; Lee JR; Woodruff TK
J Gynecol Oncol; 2016 Mar; 27(2):e22. PubMed ID: 26768785
[TBL] [Abstract][Full Text] [Related]
37. Fertility Preservation for Adolescent and Young Adult Transmen: A Case Series and Insights on Oocyte Cryopreservation.
Barrett F; Shaw J; Blakemore JK; Fino ME
Front Endocrinol (Lausanne); 2022; 13():873508. PubMed ID: 35685214
[TBL] [Abstract][Full Text] [Related]
38. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.
Bénard J; Duros S; El Hachem H; Sonigo C; Sifer C; Grynberg M
Future Oncol; 2016 Jul; 12(14):1731-41. PubMed ID: 27184037
[TBL] [Abstract][Full Text] [Related]
39. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
40. Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients.
Tsampras N; Gould D; Fitzgerald CT
Hum Fertil (Camb); 2017 Dec; 20(4):248-253. PubMed ID: 28423955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
